These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

WEIGHT-LOSS drugs that last week became available on the NHS will not be available through Jersey’s publicly funded healthcare system for treating obesity until September at the earliest. A government ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

With more than 600 million Chinese adults projected to be overweight by 2050, the emergence of a viable local alternative to Novo and Lilly’s blockbuster GLP-1 treatments could make weight loss drugs ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

"Falsified weight loss medicines have been detected across the world, including the UK. Some do not contain the active ingredient stated, while others contain another undeclared active ingredient," Dr ...

Renowned endocrinologist and diabetologist Dr Ambrish Mithal told IndiaToday.in talked about muscle loss after consuming ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Some weight-loss drugs are being sold directly to consumers, bypassing insurance. Catholic devotees were stunned when an ...